Mercer Global Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
Mercer Global Advisors's ADMA Position: Q3 2026 in Review
Mercer Global Advisors increased its ADMA Biologics (ADMA) stake by 50% in Q3 2026, buying an estimated $222K and bringing the position to 72,133 shares worth $723K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.
Mercer Global Advisors first reported a position in ADMA in Q2 2022 and has held it in 10 quarters since. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- Mercer Global Advisors held 72,133 shares of ADMA Biologics worth $723K as of Q3 2026.
- Mercer Global Advisors bought 23,998 ADMA Biologics shares in Q3 2026, an estimated $222K.
- ADMA Biologics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #2083 holding.
- Mercer Global Advisors first reported a position in ADMA Biologics in Q2 2022 and has held it in 10 quarters since.
- 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.